Autologous formalin-fixed tumor vaccine suppressed re-recurrence of HCV-related hepatocellular carcinoma following 29 unsuccessful treatments with extensive conventional therapy: a case report
World Journal of Surgical Oncology, 07/17/2012
Inui T et al. – The authors report a case of a patient with repeat recurrent hepatocellular carcinoma (HCC) that was associated with hepatitis C virus (HCV) who had endured 29 episodes of HCC recurrence despite a variety of therapy using conventional methods. Finally, treatment with a single course of autologous formalin–fixed tumor vaccine resulted in suppression of potential further re–recurrence of HCC for more than 43 months without any additional treatment.